Jeff Carroll is Senior Scientist, Team Lead ADC Express, Process and Analytical Development at MilliporeSigma. He has been with the company for over 5 years and is currently a Group Leader in Process and Analytical Development for Bio-conjugation/Bio-organic contract manufacturing. He is an active champion for incorporation of Single Use platforms and Process Analytical Technologies (PAT) for ADC production. Carroll previously worked at Monsanto Co. and Pfizer Inc. specializing in small molecule synthesis for herbicides and pharmaceuticals which is showcased in 11 publications and 12 patents to date. Carroll has a bachelor’s degree in Chemistry from the University of Illinois-Champaign, Champaign, IL and a master’s degree in Organic Synthesis from Rice University, Houston, TX with his thesis on perfluoro-cholesterol analogs as treatment for Familial Hypercholesterolemia.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.